0001104659-19-003196.txt : 20190124 0001104659-19-003196.hdr.sgml : 20190124 20190124174536 ACCESSION NUMBER: 0001104659-19-003196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190122 FILED AS OF DATE: 20190124 DATE AS OF CHANGE: 20190124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Souza Marcio CENTRAL INDEX KEY: 0001707657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 19540776 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 a4.xml 4 X0306 4 2019-01-22 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001707657 Souza Marcio C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Operating Officer Common Stock 2019-01-22 4 A 0 1925 0 A 4667 I By Spouse Stock Option (Right to Buy) 33.02 2019-01-22 4 A 0 112500 0 A 2029-01-21 Common Stock 112500 112500 D Stock Option (Right to Buy) 33.02 2019-01-22 4 A 0 25000 0 A 2029-01-21 Common Stock 25000 25000 D Stock Option (Right to Buy) 33.02 2019-01-22 4 A 0 6825 0 A 2029-01-21 Common Stock 6825 6825 I By Spouse Restricted stock unit granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. /s/ Avraham S. Adler, attorney-in-fact 2019-01-24